Stay updated on Filgotinib Alone and With MTX in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Alone and With MTX in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the Filgotinib Alone and With MTX in Rheumatoid Arthritis Clinical Trial page
- Check2 days agoChange DetectedThe revision identifier in the footer changes from v3.7.2 to v3.8.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide notice announces updates and FAQs about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check16 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now shows a 403 Forbidden error page, blocking access to the study record; the page content displays a standard 403 message with a Home button, replacing the previous study details.SummaryDifference17%

- Check44 days agoChange DetectedRelated topics were added, including Rheumatoid arthritis, and a MedlinePlus Genetics link, expanding accessible context and resources. The page footer now shows Revision: v3.7.0, indicating a version update.SummaryDifference0.1%

Stay in the know with updates to Filgotinib Alone and With MTX in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Alone and With MTX in Rheumatoid Arthritis Clinical Trial page.